BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang JH, Li Y, Wang R, Geddert H, Guo W, Wen DG, Chen ZF, Wei LZ, Kuang G, He M, Zhang LW, Wu ML, Wang SJ. NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol 2003; 9(7): 1390-1393 [PMID: 12854127 DOI: 10.3748/wjg.v9.i7.1390]
URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1390.htm
Number Citing Articles
1
Toru Hiyama, Masaharu Yoshihara, Shinji Tanaka, Kazuaki Chayama. Genetic polymorphisms and esophageal cancer riskInternational Journal of Cancer 2007; 121(8): 1643 doi: 10.1002/ijc.23044
2
Manzoor Ahmad Malik, Showkat Ali Zargar, Balraj Mittal. Role of NQO1 609C>T and NQO2 −3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysisMolecular Biology Reports 2012; 39(9): 9095 doi: 10.1007/s11033-012-1781-y
3
Hongping Yu, Hongliang Liu, Li-E Wang, Qingyi Wei, Amanda Ewart Toland. A Functional NQO1 609C>T Polymorphism and Risk of Gastrointestinal Cancers: A Meta-AnalysisPLoS ONE 2012; 7(1): e30566 doi: 10.1371/journal.pone.0030566
4
Shinobu Ikeda, Shizuka Sasazuki, Syusuke Natsukawa, Kozo Shaura, Yoichi Koizumi, Yoshio Kasuga, Sumiko Ohnami, Hiromi Sakamoto, Teruhiko Yoshida, Motoki Iwasaki, Shoichiro Tsugane. Screening of 214 Single Nucleotide Polymorphisms in 44 Candidate Cancer Susceptibility Genes: A Case–Control Study on Gastric and Colorectal Cancers in the Japanese PopulationThe American Journal of Gastroenterology 2008; 103(6): 1476 doi: 10.1111/j.1572-0241.2008.01810.x
5
Asher Begleiter, Alia Norman, Darren Leitao, Teresa Cabral, Donna Hewitt, Sushu Pan, Jennifer R. Grandis, Jill M. Siegfried, Samy El-Sayed, Donna Sutherland, David A. Ross, Paul D. Kerr. Role of NQO1 polymorphisms as risk factors for squamous cell carcinoma of the head and neckOral Oncology 2005; 41(9): 927 doi: 10.1016/j.oraloncology.2005.05.004
6
Sanjib Dey, Nillu Ghosh, Debjit Saha, Kousik Kesh, Arnab Gupta, Snehasikta Swarnakar, Redhwan Ahmed Al Naggar. Matrix Metalloproteinase-1 (MMP-1) Promoter Polymorphisms are Well Linked with Lower Stomach Tumor Formation in Eastern Indian PopulationPLoS ONE 2014; 9(2): e88040 doi: 10.1371/journal.pone.0088040
7
Toshihito Kosaka, Junji Yoshino, Kazuo Inui, Takao Wakabayashi, Takashi Kobayashi, Shinya Watanabe, Shigekazu Hayashi, Yoshifumi Hirokawa, Taizo Shiraishi, Takayuki Yamamoto, Mayumi Tsuji, Takahiko Katoh, Masatoshi Watanabe. Involvement of NAD(P)H:Quinone Oxidoreductase 1 and Superoxide Dismutase Polymorphisms in Ulcerative ColitisDNA and Cell Biology 2009; 28(12): 625 doi: 10.1089/dna.2009.0877
8
Upendra Yadav, Pradeep Kumar, Vandana Rai. “NQO1Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.”Nutrition and Cancer 2018; 70(4): 557 doi: 10.1080/01635581.2018.1460674
9
S Danson, T.H Ward, J Butler, M Ranson. DT-diaphorase: a target for new anticancer drugsCancer Treatment Reviews 2004; 30(5): 437 doi: 10.1016/j.ctrv.2004.01.002
10
Fei Liu, Limei Luo, Yonggang Wei, Wentao Wang, Bo Li, Lvnan Yan, Tianfu Wen. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese populationTumor Biology 2013; 34(1): 47 doi: 10.1007/s13277-012-0509-x
11
Sanjib Dey, Sami Stalin, Arnab Gupta, Debjit Saha, Kousik Kesh, Snehasikta Swarnakar. Matrix metalloproteinase3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian populationMolecular Carcinogenesis 2012; 51(S1) doi: 10.1002/mc.21837
12
Hong-Yu Zhao, Yan Gu, Yong-Xiang Yi. NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysisTumor Biology 2014; 35(3): 2199 doi: 10.1007/s13277-013-1292-z
13
Y. Zhang, Z.T. Wang, J. Zhong. Meta-analysis demonstrates that the NAD(P)H: quinone oxidoreductase 1 (NQO1) gene 609 C>T polymorphism is associated with increased gastric cancer risk in AsiansGenetics and Molecular Research 2012; 11(3): 2328 doi: 10.4238/2012.August.13.6
14
Khalid Moumad, Wafa Khaali, Abdellatif Benider, Wided Ben Ayoub, Mokhtar Hamdi‐Cherif, Kada Boualga, Elham Hassen, El Khalil Ben Driss, Marilys Corbex, Meriem Khyatti. Joint effect of smoking and NQO1 C609T polymorphism on undifferentiated nasopharyngeal carcinoma risk in a North African populationMolecular Genetics & Genomic Medicine 2018; 6(6): 933 doi: 10.1002/mgg3.461
15
Nadimuthu Vinayagamoorthy, Kannan Krishnamurthi, Sivanesan Saravana Devi, Pravin K. Naoghare, Raka Biswas, Arup R. Biswas, Sreemanta Pramanik, Ashok R. Shende, Tapan Chakrabarti. Genetic polymorphism of CYP2D6∗2 C→T 2850, GSTM1, NQO1 genes and their correlation with biomarkers in manganese miners of Central IndiaChemosphere 2010; 81(10): 1286 doi: 10.1016/j.chemosphere.2010.08.047
16
Wei-Guo Hu, Jia-Jia Hu, Wei Cai, Min-Hua Zheng, Lu Zang, Zheng-Ting Wang, Zheng-Gang Zhu. The NAD(P)H: Quinine Oxidoreductase 1 (NQO1) Gene 609 C>T Polymorphism is Associated with Gastric Cancer Risk: Evidence from a Case-control Study and a Meta-analysisAsian Pacific Journal of Cancer Prevention 2014; 15(5): 2363 doi: 10.7314/APJCP.2014.15.5.2363
17
Asher Begleiter, Donna Hewitt, Spencer B. Gibson, James B. Johnston. Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemiaLeukemia Research 2009; 33(1): 74 doi: 10.1016/j.leukres.2008.06.030
18
Osamu Nunobiki, Masatsugu Ueda, Hikari Akise, Shinji Izuma, Kiyo Torii, Yoshiaki Okamoto, Ichiro Tanaka, Sadamu Noda, Kyoko Akashi, Taro Higashida. GSTM1, GSTT1, and NQO1 polymorphisms in cervical carcinogenesisHuman Cell 2015; 28(3): 109 doi: 10.1007/s13577-015-0111-9
19
Zhengting Wang, Jiajia Hu, Jie Zhong. Meta-Analysis of the NAD(P)H: Quinine Oxidoreductase 1 Gene 609 C>T Polymorphism with Esophageal Cancer RiskDNA and Cell Biology 2012; 31(4): 560 doi: 10.1089/dna.2011.1332
20
Sivanesan Saravana Devi, Nadimuthu Vinayagamoorthy, Meenal Agrawal, Arup Biswas, Raka Biswas, Pravin Naoghare, Sreya Kumbhakar, Kannan Krishnamurthi, Jan G. Hengstler, Matthias Hermes, Tapan Chakrabarti. Distribution of detoxifying genes polymorphism in Maharastrian population of central IndiaChemosphere 2008; 70(10): 1835 doi: 10.1016/j.chemosphere.2007.08.008
21
Arshad A. Pandith, Nighat P. Khan, Zafar A. Shah, Amin M. Shah, Saleem M. Wani, Mushtaq A. Siddiqi. Association of Bladder Cancer Risk with an NAD(P)H:Quinone Oxidoreductase Polymorphism in an Ethnic Kashmiri PopulationBiochemical Genetics 2011; 49(7-8): 417 doi: 10.1007/s10528-011-9418-8
22
Yue Fu, Leonid Buryanovskyy, Zhongtao Zhang. Quinone Reductase 2 Is a Catechol Quinone ReductaseJournal of Biological Chemistry 2008; 283(35): 23829 doi: 10.1074/jbc.M801371200
23
Xiao-Feng Huang, Chun-Mei Wang, Bo-Rong Pan, Xiao-Wen Dai, Li Fang, Jia-Ji Yang, Hua Yu, Jun Ren. Pathological characteristics of gastric leiomyoblastomaWorld Journal of Gastroenterology 2004; 10(21): 3182-3184 doi: 10.3748/wjg.v10.i21.3182
24
H. Ge, Y. Y. Cao, L. Q. Chen, Y. M. Wang, Z. F. Chen, D. G. Wen, X. F. Zhang, W. Guo, N. Wang, Y. Li, J. H. Zhang. PTENpolymorphisms and the risk of esophageal carcinoma and gastric cardiac carcinoma in a high incidence region of ChinaDiseases of the Esophagus 2008; 21(5): 409 doi: 10.1111/j.1442-2050.2007.00786.x
25
Laure-Estelle Cassagnes, Pierre Perio, Gilles Ferry, Natacha Moulharat, Mathias Antoine, Régis Gayon, Jean A. Boutin, Françoise Nepveu, Karine Reybier. In cellulo monitoring of quinone reductase activity and reactive oxygen species production during the redox cycling of 1,2 and 1,4 quinonesFree Radical Biology and Medicine 2015; 89: 126 doi: 10.1016/j.freeradbiomed.2015.07.150
26
Jolien J M Freriksen, Jody Salomon, Hennie M J Roelofs, Rene H M te Morsche, Jos W J van der Stappen, Polat Dura, Ben J M Witteman, Martin Lacko, Wilbert H M Peters. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancerJournal of Human Genetics 2014; 59(7): 381 doi: 10.1038/jhg.2014.38
27
Tang Ho, Qingyi Wei, Erich M. Sturgis. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neckHead & Neck 2007; 29(7): 682 doi: 10.1002/hed.20570
28
Jian-Hui Zhang, Xia Jin, Yan Li, Rui Wang, Wei Guo, Na Wang, Deng-Gui Wen, Zhi-Feng Chen, Gang Kuang, Li-Zhen Wei, Shi-Jie Wang. Epoxide hydrolase <italic>Tyr</italic>113<italic>His</italic> polymorphism is not associated with susceptibility to esophageal squamous cell carcinoma in population of North ChinaWorld Journal of Gastroenterology 2003; 9(12): 2654-2657 doi: 10.3748/wjg.v9.i12.2654
29
Farida S. Akhtari, Adrian J. Green, George W. Small, Tammy M. Havener, John S. House, Kyle R. Roell, David M. Reif, Howard L. McLeod, Timothy Wiltshire, Alison A. Motsinger-Reif, Francisca Vazquez. High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugsPLOS Genetics 2021; 17(8): e1009732 doi: 10.1371/journal.pgen.1009732
30
Karim Iskander, Anil K. Jaiswal. Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicityChemico-Biological Interactions 2005; : 147 doi: 10.1016/j.cbi.2005.03.019
31
H.A. Marjani, F. Biramijamal, N. Rakhshani, A. Hossein-Nezhad, R. Malekzadeh. Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from IranGenetics and Molecular Research 2010; 9(1): 239 doi: 10.4238/vol9-1gmr693
32
Lifang Hou, Nilanjan Chatterjee, Wen-Yi Huang, Andrea Baccarelli, Sunita Yadavalli, Meredith Yeager, Robert S. Bresalier, Stephen J. Chanock, Neil E. Caporaso, Bu-Tian Ji, Joel L. Weissfeld, Richard B. Hayes. CYP1A1 Val 462 and NQO1 Ser 187 polymorphisms, cigarette use, and risk for colorectal adenomaCarcinogenesis 2005; 26(6): 1122 doi: 10.1093/carcin/bgi054
33
Asher Begleiter, Donna Hewitt, Andrew W. Maksymiuk, David A. Ross, Ranjana P. Bird. A NAD(P)H:Quinone Oxidoreductase 1 Polymorphism Is a Risk Factor for Human Colon CancerCancer Epidemiology, Biomarkers & Prevention 2006; 15(12): 2422 doi: 10.1158/1055-9965.EPI-06-0661
34
Hu Yanling, Zhang Yuhong, He Wenwu, Xian Lei, Chen Mingwu. NQO1 C609T polymorphism and esophageal cancer risk: a HuGE review and meta-analysisBMC Medical Genetics 2013; 14(1) doi: 10.1186/1471-2350-14-31
35
Paul Nioi, John D. Hayes. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factorsMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2004; 555(1-2): 149 doi: 10.1016/j.mrfmmm.2004.05.023
36
Manzoor Ahmad Malik, Showkat Ali Zargar, Balraj Mittal. Role of NQO1 609C>T and NQO2-3423G>A Polymorphisms in Susceptibility to Gastric Cancer in Kashmir ValleyDNA and Cell Biology 2011; 30(5): 297 doi: 10.1089/dna.2010.1115
37
NQO1 C609T polymorphism correlated to colon cancer risk in farmers from western region of Inner MongoliaChinese Journal of Cancer Research 2012; 24(4): 317 doi: 10.1007/s11670-012-0270-0
38
Jineun Kim, Seoyun Yum, Changwon Kang, Suk-Jo Kang. Gene-gene interactions in gastrointestinal cancer susceptibilityOncotarget 2016; 7(41): 67612 doi: 10.18632/oncotarget.11701
39
Meenakshi Umar, Rohit Upadhyay, Shaleen Kumar, Uday Chand Ghoshal, Balraj Mittal. Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysisCancer Epidemiology 2012; 36(6): e373 doi: 10.1016/j.canep.2012.06.004
40
B Lajin, A Alachkar. The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysisBritish Journal of Cancer 2013; 109(5): 1325 doi: 10.1038/bjc.2013.357
41
Feng Zhu, Marie Loh, Jeffrey Hill, Sumarlin Lee, King Xin Koh, Kin Wai Lai, Manuel Salto-Tellez, Barry Iacopetta, Khay Guan Yeoh, Richie Soong. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort studyBMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-76